Trial
NCT03965624
Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Takeda Pharmaceuticals International, Inc.
Condition
Immune Thrombocytopenia
Intervention
Ninlaro
Why stopped
Decision of sponsor: impossibility of contract with Takeda
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-28